Target intelligence / Profile preview

Tudor domain-containing protein 7 (TDRD7)

Target
TDRD7
Molecular classification
RNA-binding protein, Tudor domain-containing protein, LOTUS domain-containing protein, Post-transcriptional regulator, Other
01

Overview

Tudor domain-containing protein 7 (TDRD7) is a highly conserved, multi-domain RNA-binding protein characterized by three *Tudor domains* and three *LOTUS domains*; the former typically recognize methylated arginine or lysine residues on proteins, while the latter are predicted to bind RNA and interact with DEAD-box helicases[1][4][9]. TDRD7 is a critical component of ribonucleoprotein (RNP) assemblies called chromatoid bodies in developing sperm, where it orchestrates post-transcriptional regulation, suppresses retrotransposons (such as LINE1), and ensures spermatogenesis[2][7]. In somatic tissues, especially the ocular lens, TDRD7 is involved in the post-transcriptional control of gene expression required for lens fiber cell differentiation and maintenance; deficiency leads to congenital and age-related cataracts as well as, in some cases, glaucoma[6][9]. Additionally, TDRD7 has been shown to function as an interferon-stimulated antiviral gene by interacting with AMPK and modulating autophagy pathways[3]. There are currently no drugs known to directly modulate TDRD7, and it is not considered a therapeutic target at this time. Deficiency or mutation in TDRD7 causes significant developmental defects, but therapeutic modulation is not established.

Other names
PCTAIRE2-binding proteinTrapTudor repeat associator with PCTAIRE-2CATC4TRAPepididymis secretory sperm binding proteintudor repeat associator with PCTAIRE 2PCTAIRE2BP
02

Biological functions

Post-transcriptional regulation of gene expressionRNA granule/RNP assembly and remodelingSpermatogenesis and haploid germ cell developmentSuppression of retrotransposons (e.g., LINE1)Regulation of lens fiber cell morphogenesis and differentiationInhibition of AMPK-mediated autophagy (as an interferon-stimulated gene)Other
03

Disease associations

Male infertility (caused by spermatogenic defects/azoospermia)Congenital and age-related cataractGlaucomaOther
04

Safety considerations

Disruption or deficiency causes congenital cataracts and male infertilityNo known pharmacological targeting or drug-related safety concerns
05

Biomarkers

Possibly TDRD7 protein or genetic variants for congenital/age-related cataractPossibly TDRD7 variants for male infertility

Beyond the preview

Go deeper on Tudor domain-containing protein 7 (TDRD7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tudor domain-containing protein 7 (TDRD7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call